Possible Acquisition

Brainspark PLC 20 May 2002 For Immediate Release 20th May, 2002 BRAINSPARK PLC ('Brainspark') Acquisition of Infusion SpA ('Infusion') THE BOARDS OF INFUSION AND BRAINSPARK HAVE APPROVED PROPOSALS TO ASSESS THE POTENTIAL ACQUISITION OF CERTAIN ASSETS AND LIABILITIES OF INFUSION SPA BY BRAINSPARK PLC. APPOINTED A LEADING INTERNATIONAL ACCOUNTANCY PRACTICE TO PROVIDE AN INDEPENDENT VALUATION OF THE ASSETS OF BOTH COMPANIES. Milan, 20 May 2002 - The Board of Infusion and Brainspark announce that they have entered into discussions with a view to assessing the potential acquisition by Brainspark of certain of the assets and liabilities of Infusion for a consideration to be satisfied by an issue of Brainspark Ordinary Shares. It is intended that the transaction, which will be treated as a related party transaction under the AIM Rules, will be structured so that it is not a reverse takeover under those Rules. The Board of Infusion and Brainspark have appointed Ernst &Young to conduct an independent valuation of both companies. Brainspark Ordinary Shares are traded on the Alternative Investment Market of the London Stock Exchange plc. Infusion is a wholly owned subsidiary of AISoftw@re SpA ('AISoftw@re'). AISoftw@re is listed on Nasdaq Europe (AISW) and the Italian Nuovo Mercato (AISW) and owns approximately 65.5 per cent. of the issued share capital of Brainspark. Brainspark Brainspark (www.brainspark.com) is an incubator business which has focused its investments on companies operating in the area of online professional services. Based in London and listed on AIM (BSP), Brainspark currently holds a portfolio of eight investments. AISoftw@re AISoftw@re (www.ais.it) was founded in 1983 and with consolidated group sales in 2001 of over 26.7 million Euro and specialises in the development of technologically advanced knowledge processing and decision support data-mining Internet and Intranet solutions. The technical expertise acquired and the large portfolio of proprietary products enable AISoftw@re to be positioned as the leading company in software solutions for financial markets, medical imaging and broadband Internet. AISoftw@re is pursuing a programme of growth both through acquisitions and equity investments in companies in tune with the parent company's business model, as well as through a policy of international expansion. A program rationalising the structure of AISoftw@re into three business areas has recently been undertaken, resulting in the setting up of three subsidiary companies: AISoftw@re Medical Solutions & Program Spa, AISoftw@re Technologies & Solutions Spa and AISoftw@re Professional Services Spa. By the end of 2002, the present banking & insurance business area of AISoftw@re, which specialises in software solutions for the banking and financial community, will form the fourth industrial subsidiary company of the AISoftw@re Group under the name AISoftw@re Financial Solutions Spa. The AISoftw@re Group includes and has over 460 employees and collaborators. Its headquarters are in Milan and it also has offices in Rome, Florence, Trento, Vicenza and Bologna. Infusion Infusion (www.infusion.it) has been established to acquire and manage the investments of the AISoftw@re Group. AISoftw@re Group's strategy is that Infusion invests in advanced technology companies, focused on creating and delivering content and services via Internet. The Company is incorporated in Milan (Italy), with a 8.5 million Euros share capital and is 99.99 per cent. owned by AISoftw@re Its current investment portfolio includes: ACS (23 per cent.), Geosim System Ltd (29.67 per cent.), Impression (20 per cent.), Kstones (73.05 per cent.), Ludonet (35 per cent.) and Mindmotion (31.93 per cent.). For further information: Marco Mancini Tel: +39-02-28014 Fax: +39-02-2610853 E-mail: mmancini@ais.it This information is provided by RNS The company news service from the London Stock Exchange